GT Biopharma Inc.

NASDAQ: GTBP · Real-Time Price · USD
1.49
0.15 (11.19%)
At close: Aug 18, 2025, 10:48 AM

GT Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.44 -1.36 -40.54 -44.41
PEG Ratio
-0.02 -0.00 0.60 0.65
PS Ratio
n/a n/a n/a n/a
PB Ratio
-3.46 1.38 72.16 117.58
P/FCF Ratio
-0.45 -1.16 -55.64 -165.08
P/OCF Ratio
-0.45 -1.16 -55.64 -165.08
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a 0.01 0.01 0.00
Quick Ratio
0.72 2.12 3.35 3.14
Current Ratio
0.72 2.12 3.35 3.14
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a -63.74 -2.66K -80.1
Return on Equity
7.88 -1.02 -1.78 -2.65
Return on Assets
-3.11 -0.54 -1.25 -1.8
Return on Invested Capital
8.60 -1.8 -1.79 -2.62
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a